Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging

Christian Schmidkonz; Torsten Kuwert; Armin Atzinger; Michael Cordes; Georg Schett; Andreas Ramming; Theresa Götz

doi:10.2967/jnumed.122.264205

Research ArticleThe State of the Art

Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging

Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, Michael Cordes, Georg Schett, Andreas Ramming and Theresa Götz

Journal of Nuclear Medicine December 2022, 63 (12) 1786-1792; DOI: https://doi.org/10.2967/jnumed.122.264205

Christian Schmidkonz

1Department of Nuclear Medicine, Friedrich–Alexander University Erlangen–Nürnberg and University Hospital Erlangen, Erlangen, Germany;

2Institute for Medical Engineering, Technical University of Applied Sciences Amberg–Weiden, Weiden, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Torsten Kuwert

1Department of Nuclear Medicine, Friedrich–Alexander University Erlangen–Nürnberg and University Hospital Erlangen, Erlangen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Armin Atzinger

1Department of Nuclear Medicine, Friedrich–Alexander University Erlangen–Nürnberg and University Hospital Erlangen, Erlangen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Cordes

1Department of Nuclear Medicine, Friedrich–Alexander University Erlangen–Nürnberg and University Hospital Erlangen, Erlangen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Georg Schett

3Rheumatology and Immunology, Department of Internal Medicine 3, Friedrich–Alexander University Erlangen–Nürnberg and University Hospital Erlangen, Erlangen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Ramming

3Rheumatology and Immunology, Department of Internal Medicine 3, Friedrich–Alexander University Erlangen–Nürnberg and University Hospital Erlangen, Erlangen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Theresa Götz

2Institute for Medical Engineering, Technical University of Applied Sciences Amberg–Weiden, Weiden, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 63, Issue 12

December 1, 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging

Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, Michael Cordes, Georg Schett, Andreas Ramming, Theresa Götz

Journal of Nuclear Medicine Dec 2022, 63 (12) 1786-1792; DOI: 10.2967/jnumed.122.264205

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging

Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, Michael Cordes, Georg Schett, Andreas Ramming, Theresa Götz

Journal of Nuclear Medicine Dec 2022, 63 (12) 1786-1792; DOI: 10.2967/jnumed.122.264205

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

fibroblast activation protein
inflammatory diseases
PET
Molecular Imaging
fibrosis

Main menu

User menu

Search

Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords